SEC Form 4 · accession 0001209191-17-065896
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nick Leschly
Officer — President and CEO · Director
Period of report
Dec 13, 2017
Accepted (ET)
Dec 15, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 13, 2017 | M | 37,873 | $5.5004 | A | 293,232 | D | |
| Common StockF2 | Dec 13, 2017 | S | 14,947 | $181.722 | D | 278,285 | D | |
| Common StockF3 | Dec 13, 2017 | S | 27,797 | $182.4893 | D | 250,488 | D | |
| Common StockF4 | Dec 13, 2017 | S | 19,221 | $183.4565 | D | 231,267 | D | |
| Common StockF5 | Dec 13, 2017 | S | 18,930 | $184.5288 | D | 212,337 | D | |
| Common StockF6 | Dec 13, 2017 | S | 16,369 | $185.4139 | D | 195,968 | D | |
| Common StockF7 | Dec 13, 2017 | S | 12,006 | $186.5618 | D | 183,962 | D | |
| Common StockF8 | Dec 13, 2017 | S | 5,700 | $187.5675 | D | 178,262 | D | |
| Common StockF9 | Dec 13, 2017 | S | 2,530 | $188.4907 | D | 175,732 | D | |
| Common Stock | holding | — | — | — | 17,186 | I | Nick Leschly 2001 Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F10 | $5.5004 | Dec 13, 2017 | M | 37,873 | D | — | Jan 16, 2023 | Common Stock | 37,873 | 203,355 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2016.
- F10This option to purchase shares of our common stock was granted on January 16, 2013 with performance-based vesting criteria that were met as of January 1, 2013. The shares underlying these options vested as follows: 25% vested on January 1, 2014, with the remainder of the shares vesting in equal monthly installments over the following three years.
- F2The range of prices for the transaction reported on this line was $181.0500 to $182.0000. The average weighted price was $181.7220. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range of prices for the transaction reported on this line was $182.0500 to $183.0000. The average weighted price was $182.4893. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The range of prices for the transaction reported on this line was $183.0500 to $184.0000. The average weighted price was $183.4565. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The range of prices for the transaction reported on this line was $184.0500 to $185.0000. The average weighted price was $184.5288. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The range of prices for the transaction reported on this line was $185.0500 to $186.0000. The average weighted price was $185.4139. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7The range of prices for the transaction reported on this line was $186.0500 to $187.0000. The average weighted price was $186.5618. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F8The range of prices for the transaction reported on this line was $187.0500 to $188.0000. The average weighted price was $187.5675. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F9The range of prices for the transaction reported on this line was $188.1500 to $188.8000. The average weighted price was $188.4907. The reporting person will provide, upon request by the SEC, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.